Modulation of EGFR signalling by modulation of sphingosine kinase signalling

Details for Australian Patent Application No. 2006261582 (hide)

Owner Medvet Science Pty. Ltd.

Inventors Xia, Pu; Vadas, Mathew Alexander; Sukocheva, Olga

Agent Davies Collison Cave

Pub. Number AU-A-2006261582

PCT Pub. Number WO2006/135967

Priority 2005903259 21.06.05 AU

Filing date 21 June 2006

Wipo publication date 28 December 2006

International Classifications

C12N 9/00 (2006.01) Enzymes, e.g. ligases (6.)

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 35/00 (2006.01) Antineoplastic agents

C12N 9/99 (2006.01) Enzymes, e.g. ligases (6.) - Enzyme inactivation by chemical treatment

Event Publications

10 January 2008 PCT application entered the National Phase

  PCT publication WO2006/135967 Priority application(s): WO2006/135967

19 January 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006261583-Modulation of sphingosine kinase signalling

2006261581-Cross linking treatment of polymer membranes